Target intelligence / Profile preview

Keratin 18 pseudogene 31 (KRT18P31)

Target
KRT18P31
Molecular classification
Other (processed pseudogene; not a true protein family member)
01

Overview

Keratin 18 pseudogene 31 (KRT18P31) belongs to a group of processed pseudogenes derived from the keratin 18 (KRT18) gene, which in its functional form encodes an intermediate filament protein expressed in simple epithelial tissues. Pseudogenes such as KRT18P31 result from gene duplication or retrotransposition events and do not contain an intact coding sequence or produce functional proteins, as they lack critical exons and regulatory elements necessary for gene expression. These pseudogenes are distributed across the human genome, with at least 77 processed pseudogenes noted for KRT18, none of which possess protein-coding potential. KRT18P31 is not expressed at the protein level, has no direct biological function, and is not implicated as a target in disease, therapy, or biomarker development. Its only relevance is for genomic annotation and evolutionary studies pertaining to the expansion of the keratin gene family. KRT18P31 is a non-coding, nonfunctional pseudogene—it is not a valid drug target or receptor, and should not be annotated as such. All clinically relevant keratin 18 biology relates to the parent gene KRT18, not its pseudogenes.

Other names
KRT18P31

Beyond the preview

Go deeper on Keratin 18 pseudogene 31 (KRT18P31).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Keratin 18 pseudogene 31 (KRT18P31).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call